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background: Animal studies have demonstrated better embryo development in vivo than in vitro. This pilot study tested the feasibility
of using a novel in utero culture system (IUCS) to obtain normal human fertilization and embryo development.
methods: The IUCS device comprised a perforated silicone hollow tube. The study included 13 patients (,36 years) undergoing a ﬁrst
intracytoplasmic sperm injection (ICSI) treatment and 167 metaphase II oocytes in three groups. In Group 1, 1–2 h after ICSI, sibling oocytes
were assigned to IUCS or conventional in vitro culture. The device was retrieved on Day 1, and all zygotes were cultured in vitro till Day 5. In
Group 2, fertilized oocytes were assigned on Day 1, embryos retrieved on Day 3 and all embryos cultured till Day 5. In Group 3, after Day 0
assignment, embryos were retrieved on Day 3 for blastomere biopsy and ﬂuorescence in situ hybridization (FISH) and cultured until Day
5. The highest quality blastocysts were transferred on Day 5.
results: Fertilization and embryo development were comparable in the in vitro and IUCS arms, with a tendency towards better embryo
quality in the IUCS. FISH analysis in Group 3 revealed more normal embryos using the IUCS (P ¼ 0.049). Three clinical pregnancies and live
births were obtained: two from the IUCS arm and one from the in vitro arm.
conclusions: Our pilot study shows that this new IUCS appears to be feasible and safe, supporting normal fertilization, embryo develop-
ment and normal chromosomal segregation. Furthermore, live births are possible after the transient presence of a silicone device in the uterus.
Clinicaltrials.gov: NCT00480103.
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Introduction
Between 1 and 4% of children are born through assisted reproduction
techniques (ARTs) (Hansen et al., 2005). These techniques imply that
fertilization occurs outside the fallopian tube, and the preimplantation
embryos are cultured in vitro until transferred into the uterus. Between
patients and within one patient, embryo quality may differ consider-
ably. On the one hand, about 50% of human embryos arrested
during the ﬁrst week as a result of chromosomal abnormalities
(Munne ´ et al., 1995). On the other hand, suboptimal in vitro culture
conditions may be associated with apoptotic events in human
embryos (Hardy et al., 2001).
†The ﬁrst three authors have contributed equally.
& The Author 2009. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved.
For Permissions, please email: journals.permissions@oxfordjournals.org
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for
non-commercial purposes provided that: the original authorship is properly and fully attributed: the Journal and Oxford University Press are attributed as the original place of publication
with the correct citation details given: if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative word this must be clearly indicated. For
commercial re-use, please contact journals.permissions@oxfordjournals.org
Human Reproduction, Vol.24, No.4 pp. 790–796, 2009
Advanced Access publication on March 10, 2009 doi:10.1093/humrep/dep005In the bovine model, it has been demonstrated that the post-
fertilization environment affects embryo quality in terms of gene
expression, cryotolerance and metabolism (Wrenzycki et al., 2005,
2007; Lonergan et al., 2006; Duranthon et al., 2008). In humans,
however, there is no similar evidence from the literature.
In the current ARTs, a tendency to optimize the cost/beneﬁt ratio
exists by providing more ‘physiological’ treatment conditions, including
mild ovarian stimulation and single embryo transfer. Mimicking physio-
logical culture conditions could provide us with new insights into early
embryonic development.
The present pilot study was designed to explore the safety and
feasibility of a novel in utero encapsulation technology (Lysaght and
Aebischer, 1999) for human embryos and aimed to compare the
characteristics of the resulting embryos with their in vitro developed
counterparts, in patients younger than 36 years of age undergoing a
ﬁrst intracytoplasmic sperm injection (ICSI) treatment. The technique
involves the introduction of microinjected human oocytes into a retrie-
vable and permeable tubing system that allows optimal exchange
betweentheuterinematernalenvironmentandthedevelopingembryo.
Materials and Methods
Study design
The pilot study was carried out at the Centre for Reproductive Medicine,
UZ Brussel. The in vitro fertilization laboratory is certiﬁed according to
ISO15 189. All patients included in the study gave written informed
consent.
Individual oocytes/embryos from patients of ,36 years old undergoing
a ﬁrst ICSI treatment were randomly assigned to either the in vivo, in utero
culture system (IUCS) or the in vitro culture system. If less than eight meta-
phase II (MII) oocytes were obtained on the day of oocyte retrieval, then
the patient was excluded from the study. Other exclusion criteria were
endometriosis, polycystic ovary syndrome and severe male-factor inferti-
lity. A total of 13 patients were included and numbered consecutively
according to the order of enrolment. Overall, 167 MII oocytes were ana-
lysed. Three distinct groups were used in order to compare fertilization,
embryo development and chromosomal constitution obtained in vivo
and in vitro. In Group 1, half of the oocytes were inserted into the
device shortly after microinjection (Day 0) and retrieved on Day 1 in
order to observe fertilization. In Group 2, half of the in vitro fertilized
oocytes were inserted on Day 1 and retrieved on Day 3 in order to
compare embryo development. In Group 3, half of the injected oocytes
were inserted into the device shortly after microinjection (Day 0) and
retrieved on Day 3 in order to compare embryo development and chro-
mosomal constitution (proof of normal fertilization). The best morphologi-
cally graded (euploid) blastocysts were transferred into the uterus on
Day 5.
The in vivo culture device
The encapsulation system (Fig. 1) is composed of a 1-cm long microper-
forated hollow silicone elastomer tubing with an outer diameter of
0.75 mm and an inner diameter of 0.43 mm. Eight longitudinal lines of
Figure 1 Diagram of the IUCS used in women undergoing ICSI: (a) microdrilled silicone segment containing the oocytes/embryos; (b) stabilization
segment; (c) extraction segment; (d) scanning electron microscopy of the drilled silicone segment (magniﬁcation  25); (e) high magniﬁcation of a
laser-drilled hole (scanning electron microscopy, magniﬁcation  1000); (f) schematic representation of the device position in the uterine cavity.
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The size of the holes does not allow the embryos to escape the
capsule, but allows exchange of nutrients, endometrial cells and other cel-
lular and non-cellular components. The proximal part of the tube can be
opened/closed to load/retrieve oocytes/embryos using a titanium
hooking device attached to an unperforated silicone tube with an outer
diameter similar to the capsule. The plain silicone tubing is reinforced by
a stainless steel spiral wire. A polypropylene ﬁlament is ﬁxed to the
distal end of the silicone tubing to allow the extraction of the device.
This IUCS can be loaded into a standard embryo transfer catheter
(Prince Medical, Ercuis, France) for introduction into the uterine cavity.
A sterile tampon is placed into the vagina in order to keep the device in
place. Biocompatibility and toxicity tests have been performed in an in
vitro bovine model (unpublished data). Materials used for the manufacture
of the IUCS device are FDA USP class VI and ISO 13 485 approved for
medical applications.
Ovarian stimulation protocol
Recombinant FSH (rFSH) (Puregon
w, Organon) and GnRH antagonist
Ganirelix (Orgalutran
w, Organon) were used for ovarian stimulation. In
summary, a low-dose, monophasic-combined oral contraceptive pill
(OCP) containing 150 mg of desogestrel and 30 mg of ethinylestradiol
(Marvelon
w, Organon) was administered for 2 weeks starting on Day 1
of the pre-ARTs cycle. rFSH at a dose of 200 IU per day was started 5
days after discontinuation of the OCP. Ganirelix was initiated at a daily
dose of 0.25 mg on Day 6 of the rFSH stimulation. Oocyte maturation
was induced by the administration of 10 000 IU of hCG (Pregnyl
w,N V
Organon) when at least three follicles  17 mm diameter were present
on ultrasound scan. Oocyte retrieval was carried out 36 h after Pregnyl
w
injection by vaginal ultrasound-guided puncture of ovarian follicles.
ICSI, fertilization and embryo culture
Pooled cumulus–oocyte complexes were denuded of cumulus cells. MII
oocytes were injected by a qualiﬁed laboratory technician with a single
fresh motile spermatozoon using ICSI (Van Landuyt et al., 2005). Injected
oocytes were placed in individual 25 ml droplets of cleavage medium
(Medicultw) under parafﬁn oil (Irvine Scientiﬁc
w).
Group 1
Group 1 was designed to test the ability to obtain normal fertilization after
18 h in vivo incubation using the IUCS (Fig. 2). Eighty-one cumulus–oocyte
complexes were retrieved from seven patients (mean of 11.6 per patient).
A total of 79 MII oocytes were microinjected with ejaculated sperm from
the partner. Half of the survived oocytes were subjected to in vivo culture
1 to 2 h post-injection. Randomization for allocation to in vivo or in vitro
culture was performed as follows. After ICSI, oocytes were randomly allo-
cated to individual culture droplets. In the odd-numbered patients, the ﬁrst
half of the culture droplets with injected oocytes was allocated to the in
vitro arm and the other half was allocated to the IUCS arm. In the even-
numbered patients, the opposite allocation procedure was performed,
i.e. with the ﬁrst half being allocated to the IUCS and the second half
being further cultured in vitro. In case of an uneven oocyte number, an
Figure 2 Timeline for the pilot study, designed to test the utility of the IUCS in supporting normal human fertilization and embryo development. For
each patient, after ICSI, half of the injected oocytes were allocated to the IUCS arm (in vivo) and the other half to the in vitro arm. The times were
selected to assess the IUCS for the following aspects of early development—Group 1: Day 0 to 1, in vivo fertilization; Group 2: Day 1 to 3, in vivo early
embryo development and Group 3: Day 0 to 3, in vivo fertilization and early embryo development.
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assigned to the IUCS arm were loaded into the capsule (Fig. 1) under
microscopic control at  5t o 10 magniﬁcation. Loading was performed
in a dish ﬁlled with HEPES-buffered medium kept at 378C. The device was
inserted into a catheter and transferred to the uterus. After in vivo culture
for 18 h, the IUCS was removed from the uterine cavity and immediately
placed into HEPES-buffered medium at 378C. The silicone capsule was
opened at both ends, and the zygotes were recovered by aspirating the
content of the capsule with a glass pipette or by ﬂushing the contents
with a blunt needle. Zygotes were individually placed into 25 ml droplets
of cleavage medium under oil. Fertilization obtained in vivo or in vitro
was evaluated by the appearance of two pronuclei at 18 to 20 h after injec-
tion, and all zygotes were further cultured in vitro. Embryo development
was evaluated daily by the assessment of number of cells, fragmentation
rate, cell size, symmetry, granulation, vacuolization and multinucleation.
The different parameters were combined in an embryo score, ranging
from Q1 (excellent) to Q4 (poor).
In the morning of Day 3, all embryos were transferred to blastocyst
medium (Medicultw). Embryos were evaluated until transfer (Day 5) or
until freezing (Day 5 or 6). For blastocyst evaluation, the scoring system
of Gardner and Schoolcraft (1999) was used, and a combined embryo
score (Q1 to Q4) was given to the blastocysts, considering blastocyst
grade, fragmentation, completeness of compaction and estimation of the
number of cells in the inner cell mass and trophectoderm. The morpho-
logically best embryos were transferred into the uterus. Only supernumer-
ary blastocysts of Q1 and Q2 (excellent and good, respectively) were
cryopreserved with glycerol as cryoprotectant.
Group 2
Group 2 was designed to compare the effect of both culture systems on
early embryo development at 66 h post-injection (Fig. 2). Only normally
fertilized oocytes (two pronuclei) were randomized for in vivo or in vitro
culture. Forty-six cumulus–oocyte complexes were retrieved from three
patients (mean of 15.3 per patient). A total of 41 MII oocytes were micro-
injected. On Day 1, half of the normally fertilized oocytes were cultured in
vivo and the other half in vitro. Random allocation to the in vitro or the in
vivo arm was similar to the procedure already described for Group
1. Embryos were retrieved from the capsule on Day 3 and further cultured
in vitro up to Day 5 or 6.
Group 3
Group 3 was designed to examine the feasibility of obtaining both normal
fertilization and normal early embryo development using the IUCS. From
three patients, 57 cumulus–oocyte complexes were retrieved. A total of
47 MII oocytes were injected and the surviving oocytes were randomly
allocated to in vivo or in vitro culture (as described earlier) 1 to 2 h after
microinjection. Embryos were retrieved from the capsule on Day 3. In
order to assess normal fertilization and euploidy, in vivo and in vitro
embryos were biopsied and analysed by ﬂuorescence in situ hybridization
(FISH). Embryos were further cultured in vitro up to Day 5 or 6.
Embryo biopsy and FISH protocol
Embryo biopsy was performed on Day 3 embryos with  5 blastomeres
and  50% fragmentation.
Before the biopsy, embryos were placed in a droplet containing Ca
2þ
and Mg
2þ free medium (G-PGD, Vitrolife, Kungsbacka, Sweden). Laser
technology was used to perforate the zona pellucida. One blastomere
was withdrawn with a bevelled aspiration pipette and spread on a slide
according to the HCl/Tween-20 method (Staessen et al., 2003).
In all blastomeres, ﬁve chromosomes were analysed by FISH in a
one-step procedure. Centromeric probes for chromosomes X, Y and
18, and locus-speciﬁc probes for chromosomes 13 and 21 were used
for hybridization (Vysis Inc., Downers Grove, IL, USA).
The percentage of normal embryos in each arm was deﬁned as the
number of euploid embryos upon the number of embryos for biopsy.
Embryo transfer and pregnancy test
In each group, the best blastocysts, regardless of culture condition (in vivo
or in vitro), were transferred to the uterine cavity on Day 5. In case of
similar quality, preference was given to the in vitro embryo. A rise in
serum hCG on two consecutive occasions from 11 days after embryo
transfer indicated pregnancy. A clinical pregnancy was deﬁned by the pre-
sence of a gestational sac with fetal heart beat at ultrasonography after 7
weeks of pregnancy.
Statistical evaluation
Categorical data are presented as number of cases and percentages for
each culture arm. For each group, the in vivo and in vitro culture arms
were compared by using Fisher’s exact probability test, with a value of
0.05 as the limit of signiﬁcance. The Statistical Package for the Social
Sciences version 16.0 for Windows (SPSS Inc., Chicago, IL, USA) was
used for statistical analysis.
Registration
This study was registered with number NCT00480103 in the Clinical Trial
web (www.clinicaltrials.gov), and it received institutional review board
approval by the Ethics Committee of the Centre for Reproductive Medi-
cine, UZ Brussel, Brussels, Belgium.
Results
Group 1
In Group 1, 74 out of 79 MII oocytes were successfully injected and
randomly assigned to in vivo or in vitro culture. Five injected oocytes
degenerated shortly after ICSI, before randomization was performed.
In patients with an odd number of successfully injected oocytes (six
cases), the extra oocyte was allocated to in vitro culture. Overall, 40
injected oocytes were cultured in vitro, while 34 injected oocytes
were loaded into the capsule and cultured within the IUCS inside
the maternal uterus for 18 h (mean of 4.9 per capsule, range 3–8).
From the IUCS, 32 out of 34 oocytes were successfully retrieved
and 23 showed normal fertilization (2PN, 67.6%) (Table I). In vitro,
30 out of 40 oocytes showed 2PN (75%). On Day 3, 15 out of 23
embryos from the in vivo arm (65.2%) were good-quality embryos
(Q1 þ Q2) versus 14 of the 30 in vitro cultured siblings (46.7%).
A similar trend was observed on Day 5, the day of embryo transfer
for all seven patients. Three embryos were selected for transfer
from the in vitro arm, and four embryos were chosen from the IUCS
arm. A similar number of embryos was cryopreserved in both arms.
Three of the seven patients in Group 1 showed a clinical pregnancy:
two of them with a blastocyst of the IUCS arm and one with a blas-
tocyst of the in vitro arm. Three healthy children were born: two
from IUCS and one from in vitro culture.
Group 2
In Group 2, a total of 41 MII oocytes were microinjected, 32 sur-
vived and 29 normally fertilized zygotes were randomly assigned to
in vivo or in vitro culture (Table II). Fifteen zygotes were cultured in
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IUCS inside the uterus for 48 h (mean of 4.7 per capsule, range 3–
8). On Day 3, 13 out of 14 in vivo embryos were successfully
retrieved, while one was damaged. The morphological scores
revealed that 8 out of 14 embryos showed good quality (Q1 þ
Q2) (57.1%) in the IUCS arm, while 5 out of 15 good embryos
were observed (33.3%) in the in vitro arm. The morphological
scores on Day 5 showed a similar trend. Two patients received
one embryo for transfer and one patient exceptionally received
two embryos. Three embryos were selected from the IUCS, and
one embryo was chosen from the in vitro arm. One biochemical
pregnancy was obtained in the patient who received one IUCS
and one in vitro-derived embryo. No fetal sac was observed on
ultrasound.
Group 3
In Group 3, 57 cumulus–oocyte complexes were retrieved from three
patients (mean of 19.0 oocytes per patient). A total of 47 MII oocytes
were microinjected, 3 degenerated before randomization, resulting in
44 surviving oocytes of which 22 were cultured in vitro and 22 in the
IUCS (Table III). On Day 3, 19 out of 22 embryos were successfully
retrieved from IUCS. As it is not possible to evaluate the euploidy
of the in vivo arm embryos at the time of morphological qualiﬁcation,
the proportion of embryo quality has to be calculated on allocated
oocytes instead of fertilized oocytes (Table III). The morphological
scores on Days 3 and 5 showed a non-signiﬁcant trend in favour of
the in vivo culture (63.6% versus 45.5% good quality on Day 3 and
50.0% versus 22.7% on Day 5). On Day 3, biopsy was performed in
13 in vitro embryos and 17 in vivo embryos. FISH analysis revealed
euploidy in 15 out of 17 biopsied IUCS embryos and in 7 out of 13
biopsied in vitro embryos (P ¼ 0.049, Table III). For two in vitro
embryos, no FISH diagnosis was obtained. Embryo transfer was per-
formed in two out of three patients: one patient with an embryo of
the in vivo arm and one patient with an embryo of the in vitro arm.
The embryos of the third patient, although genetically normal,
..................................................
........................................................................................
Table I Results of fertilization and embryo
development in vivo (using IUCS) and in vitro (Group 1)
7 patients
81 COC
1
79 MII
2 oocytes
74 successfully injected MII oocytes
in vitro culture in vivo
culture
Day 0
Allocated injected oocytes 40 34
Day 1*
2PN 30/40 75.0% 23/34 67.6%
1PN 0/40 0.0% 2/34 5.9%
 3PN 7/40 17.5% 4/34 11.8%
Zero PN 3/40 7.5% 3/34 8.8%
Not retrieved 2/34 5.9%
Day 3**
Q1
3 5/30 16.7% 8/23 34.8%
Q2
4 9/30 30.0% 7/23 30.4%
Q3
5 10/30 33.3% 4/23 17.4%
Q4
6 6/30 20.0% 4/23 17.4%
Day 5***
Q1 4/30 13.3% 4/23 17.4%
Q2 6/30 20.0% 6/23 26.1%
Q3 5/30 16.7% 4/23 17.4%
Q4 15/30 50.0% 9/23 39.1%
Embryos for ET 3 4
Embryos frozen 9 8
1Cumulus–oocyte complexes, PN: pronuclei, ET: embryo transfer.
2Metaphase II.
3Q1: excellent quality.
4Q2: good quality.
5Q3: fair quality.
6Q4: poor quality.
Using Fisher’s exact probability test:
*P ¼ 0.29, for fertilization in the in vitro versus in vivo culture arms.
**P ¼ 0.41, for distribution of embryo quality on Day 3 in in vitro versus in vivo culture
arms.
***P ¼ 0.86, for distribution of embryo quality in in vitro versus in vivo culture arms.
....................................................
........................................................................................
Table II Results of embryo development in vivo and in
vitro (Group 2)
3 patients
46 COC
41 MII oocytes
32 successfully injected MII
oocytes
29 2PN oocytes
in vitro culture in vivo
culture
Day 1
Allocated 2PN oocytes 15 14
Day 3*
Q1 3/15 20.0% 4/14 28.6%
Q2 2/15 13.3% 4/14 28.6%
Q3 4/15 26.7% 3/14 21.4%
Q4 6/15 40.0% 2/14 14.3%
Not retrieved 1/14 7.1%
Day 5**
Q1 2/15 13.3% 2/14 14.3%
Q2 1/15 6.7% 3/14 21.4%
Q3 2/15 13.3% 3/14 21.4%
Q4 10/15 66.7% 5/14 35.7%
Not retrieved 1/14 7.1%
Embryos for ET 1 3
Embryos frozen 3 2
Using Fisher’s exact probability test:
*P ¼ 0.45, comparing the distribution of embryo quality on Day 3 in in vitro and in vivo
culture.
**P ¼ 0.39, comparing the distribution of embryo quality on Day 5 in in vitro and in vivo
culture.
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was obtained.
Technical issues
Initially, a total of 19 patients were included in the present pilot study.
However, only 13 patients were included in the comparative embryo
quality trial because of technical problems in ﬁve cases. The ﬁrst tech-
nical issue (with two devices in the ﬁrst four patients) was related to
the introduction of the IUCS into the transfer catheter. To solve this
problem, the catheter was adapted and no more difﬁculties occurred
later on. The second problem was linked to the intrauterine stabiliz-
ation of the device, as 3 out of 19 were found in the vagina on Day
3. The stabilization system was modiﬁed in order to decrease the
risk of IUCS migration. In one patient, all the oocytes cultured in
the IUCS were arrested in the one-cell stage at retrieval on Day 3
and the zona pellucida had disappeared. The cause of this observation
could not have been elucidated.
Flushing technique and tools were improved during this pilot study
and consequently the number of embryos damaged by technical pro-
cedures decreased progressively (8 embryos damaged out of 24
loaded in the ﬁrst six patients, and 1 damaged out of 80 loaded in
the last seven patients). No sterility problems were observed for all
of the embryos cultured in utero.
Discussion
Although in animal models better embryo development has been
observed in vivo than in vitro, no comparative data in the human are
available from the literature so far. The present work is the ﬁrst
report of an IUCS allowing communication between the embryos
and the endometrium and supporting the formation of normal
zygotes and good-quality embryos after microinjection, as well as
normal chromosomal segregation. The capsule can be inserted transi-
ently into the uterine cavity up to 3 days without bleeding and without
evidence of clinical impact on endometrial receptivity. Three clinical
pregnancies leading to healthy births have been achieved, two after
partial in vivo and one after in vitro culture, but all three after the tran-
sient presence of a foreign object in the uterus.
Duringthelastthreedecades,manyresearchershavetriedtooptimize
the in vitro environment for the developing embryo, either by mimicking
the in vivo composition of genital tract secretions—the ‘back-to-nature’
strategy (Menezo et al., 1984; Gardner et al., 1996; Leese et al.,
1998)—or by the ‘let the embryo choose’ strategy (Lawitts and
Biggers, 1992; Biggers and McGinnis, 2001). In the 1990s, embryos
were cultured in the presence of other cell types named co-culture.
The most relevant systems were the use of heterologous human oviduc-
tal (Yeung et al., 1992) or endometrial cells (Plachot et al., 1994), and
more recently autologous endometrium epithelial cells (Simon et al.,
1999). Finally, emerging technologies, such as microﬂuidic systems,
have tried to provide a dynamic microenvironment, in contrast to the
static microdrop culture technology (Beebe et al., 2000; Glasgow et al.,
2001). All these strategies are dealing with similar remaining problems
inherent tothe invitro system: an absence of the complexity of cross-talk
betweenthe embryoandsurroundingtissuesandﬂuid.Inaddition, phys-
icochemical conditions are far from physiological conditions, considering
exposure to environmental light outside the incubators, ﬂuctuations in
temperature and pH, and elevated oxygen levels.
OurnovelIUCSwasdesignedtocircumventmanyoftheshortcomings
inherent to the in vitro systems and appears to provide a microenviron-
ment that supports equal or superior preimplantation embryo develop-
ment, as suggested by the present data. The perforated silicone
membrane might allow speciﬁc and complex elements in the uterine
ﬂuid to migrate and interact with the developing embryo, and perhaps
protect the embryo against harmful reactive oxygen species and heavy
metal toxicity. It should, however, be recognized that culture of the
oocyte and placement of the early cleavage-stage embryo into the
........................................
........................................................................................
Table III Results of embryo development and
ﬂuorescence in situ hybridization (chromosomes X, Y,
13, 18, 21) in vivo and in vitro (Group 3)
3 patients
57 COC
47 MII oocytes
44 successfully injected MII
oocytes
in vitro
culture
in vivo
culture
Day 0
Allocated injected oocytes 22 22
Day 1
2PN oocytes 16/22 72.7%
Day 3*
Q1 6/22 27.3% 3/22 13.6%
Q2 4/22 18.2% 11/22 50.0%
Q3 4/22 18.2% 5/22 22.8%
Q4 2/22 9.1% 0/22 0.0%
Not retrieved 3/22 13.6%
Day 5**
Q1 2/22 9.1% 3/22 13.6%
Q2 3/22 13.6% 8/22 36.4%
Q3 4/22 18.2% 1/22 4.5%
Q4 7/22 31.8% 7/22 31.8%
Not retrieved 3/22 13.6%
Embryos for ET 1 1
Embryos frozen 1 9
FISH results***
Embryos biopsied 13/22 59.0% 17/22 77.3%
Normal
1/embryos biopsied 7/13 53.8% 15/17 88.2%
Abnormal/embryos biopsied 4/13 30.8% 2/17 11.8%
No FISH result 2/13 15.4% 0 0.0%
Normal/allocated injected oocytes 7/22 31.8% 15/22 68.2%
1For chromosomes X, Y, 13, 18, 21.
Using Fisher’s exact probability test:
*P ¼ 0.13, comparing the distribution of embryo quality on Day 3 in in vitro and in vivo
culture.
**P ¼ 0.28, comparing the distribution of embryo quality on Day 5 (Q1 to Q4) in in vitro
and in vivo culture.
***P ¼ 0.049, comparing normal ﬂuorescence in situ hybridization ﬁndings in in vitro and
in vivo culture.
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suggest that the uterine environment of the human meets the nutritional
requirements for normal fertilization and embryo development, resulting
ina higher proportionofeuploid embryoscompared with invitro culture.
While initially some technical problems led to damage or loss of
oocytes/embryos, these problems were largely solved during the
course of the trial. With the numbers available, we observed a non-
signiﬁcant tendency to improved embryo quality in the in vivo arm of
all three groups, even after short-term encapsulation for 18 h after
ICSI. Although the number of oocytes/embryos in this pilot study
was limited, a signiﬁcant difference in the proportion of euploid
embryos (chromosomes X, Y, 13, 18, 21) was observed in favour
of the in vivo arm. These ﬁndings open again the discussion on in
vitro culture conditions and their impact on epigenetic modiﬁcations,
abnormal chromosome segregation and gene expression.
In conclusion, this new in vivo culture system, which allows com-
munication between the embryo and the endometrium, appears to
be feasible and safe, as regards fertilization and embryo development.
The present pilot study further suggests superior embryo develop-
ment and a higher proportion of euploid embryos after in utero
culture than after conventional in vitro culture. It also demonstrates
the possibility of obtaining pregnancies after transient presence of
this device in the uterus. These interesting observations, however,
need to be conﬁrmed in a large RCT.
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